Volume 30, Supplement - Infectious Diseases and Carceral Health
SUPPLEMENT ISSUE
Prevention
HIV Risk and Interest in Preexposure Prophylaxis in Justice-Involved Persons
Table 2
Characteristic | No. (%) |
---|---|
Hepatitis C | |
>1 y ago | 36 (18) |
4–12 mo ago | 6 (3) |
1–3 mo ago | 4 (2) |
Unknown |
2 (1) |
Hepatitis B | |
>1 y ago |
4 (2) |
Gonorrhea | |
>1 y ago | 32 (16) |
4–12 mo ago | 4 (2) |
Unknown |
2 (1) |
Chlamydia | |
>1 y ago | 3 (19) |
4–12 mo ago | 3 (2) |
1–3 mo ago | 1 (<1) |
Unknown |
1 (<1) |
Syphilis | |
>1 y ago | 10 (5) |
4–12 mo ago | 7 (4) |
1–3 mo ago | 1 (<1) |
Unknown |
1 (<1) |
Mental health | |
Any issue | 142 (73) |
Depression | 96 (49) |
Anxiety | 81 (42) |
ADHD | 37 (19) |
PTSD | 63 (32) |
Bipolar | 46 (24) |
Schizophrenia |
13 (7) |
OUD† | |
Mild | 4 (2) |
Moderate | 4 (2) |
Severe |
87 (45) |
Stimulant use disorder (cocaine, methamphetamines)† | |
Mild | 7 (4) |
Moderate | 12 (6) |
Severe |
106 (56) |
Polysubstance use | |
OUD and stimulant use disorders | 55 (28) |
OUD and AUD | 9 (5) |
Stimulant use disorder and AUD | 13 (7) |
OUD/stimulant use disorder/AUD | 10 (5) |
*ADHD, attention deficit hyperactivity disorder; AUD, alcohol use disorder; OUD, opioid use disorder; PTSD, posttraumatic stress disorder. †Severity of OUD and stimulant use were based on Texas Christian University drug screen scores: mild, 2–3; moderate, 4–5; severe, >6.
Page created: November 30, 2023
Page updated: March 31, 2024
Page reviewed: March 31, 2024
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.